These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7701630)

  • 21. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA; Rosenberg H
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
    Bailly D
    Encephale; 1999; 25(6):595-602. PubMed ID: 10668603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma amino acids in ecstasy users.
    Stuerenburg HJ; Petersen K; Buhmann C; Rosenkranz M; Baeumer T; Thomasius R
    Neuro Endocrinol Lett; 2003 Oct; 24(5):348-9. PubMed ID: 14647011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
    Parrott AC; Rodgers J; Buchanan T; Ling J; Heffernan T; Scholey AB
    Hum Psychopharmacol; 2006 Jul; 21(5):285-98. PubMed ID: 16856221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperkalemia in fatal MDMA ('ecstasy') toxicity.
    Raviña P; Quiroga JM; Raviña T
    Int J Cardiol; 2004 Feb; 93(2-3):307-8. PubMed ID: 14975567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ecstasy, a new designer drug in the techno-scene].
    Kuhlmann T
    Psychiatr Prax; 1996 Nov; 23(6):266-9. PubMed ID: 9036394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Thomasius R; Schmolke M; Kraus D
    Fortschr Neurol Psychiatr; 1997 Feb; 65(2):49-61. PubMed ID: 9157047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents.
    Yen CF; Hsu SY
    J Nerv Ment Dis; 2007 Oct; 195(10):866-9. PubMed ID: 18043529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A death due to ecstasy - a case report.
    Chandra YG; Shetty AR; Jayanth SH; Hugar BS; Praveen S; Harish S
    Med Leg J; 2016 Mar; 84(1):46-8. PubMed ID: 26733334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MDMA ("Ecstasy")--a dangerous drug or psychotherapeutic drug?].
    Szukaj M
    Nervenarzt; 1994 Nov; 65(11):802-5. PubMed ID: 7816160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Criminal involvement among young male ecstasy users.
    Hendrickson JC; Gerstein DR
    Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
    Patel MM; Belson MG; Longwater AB; Olson KR; Miller MA
    J Emerg Med; 2005 Nov; 29(4):451-4. PubMed ID: 16243206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE; Montgomery C; Murphy PN
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS
    Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
    Uys JD; Niesink RJ
    Drug Alcohol Rev; 2005 Jul; 24(4):359-68. PubMed ID: 16234132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.